PNV - Banter and General Comments, page-12278

1. Considering the sheer number of foreign made pharma and devices that will be practically impossible.
2. If it is the orange candidate, then he tried this back in 2020 when President and it didn't go down well with industry (it also was limited to "essential" items).
2. PNV have a relatively low cost plant required and could set up one there if it made sense. The company may well do so in a few years anyway given the size of the US market.
3. Australia is one of the few countries where the trade deficit with the US is in our favour and Aus have negotiated exemptions with DJT on similar issues.

Remember we are essentially making light bits of foam in sterile packaging so freight costs are very small and margin is very high. Also remember AUD1.00 is circa USD 0.65 so we are a relatively low cost region to the US for high end medical manufacturing.

IMO this is a non-issue.